Barry Canton News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Why did Ginkgo Bioworks CEO Jason Kelly chop 20 million shares from his stake in the company? Is no turnaround for the shares coming?

Headlands Technologies LLC bought a new position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 29,259 shares of the company’s stock, valued at approximately $53,000. Several other large investors have also […]

Ginkgo Bioworks (NYSE:DNA – Free Report) had its target price reduced by The Goldman Sachs Group from $1.25 to $1.10 in a research note published on Monday morning, Benzinga reports. They currently have a sell rating on the stock. Several other research analysts have also recently issued reports on the company. Raymond James cut Ginkgo […]

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Get Free Report)’s stock price shot up 8.7% on Monday . The company traded as high as $1.35 and last traded at $1.32. 5,539,898 shares changed hands during trading, a decline of 76% from the average session volume of 22,781,762 shares. The stock had previously closed at $1.21. Analyst […]

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Get Free Report) major shareholder Barry Canton sold 37,650 shares of Ginkgo Bioworks stock in a transaction on Wednesday, December 6th. The stock was sold at an average price of $1.32, for a total transaction of $49,698.00. Following the sale, the insider now directly owns 12,449,854 shares of the […]